查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855916

2025年全球哺乳动物细胞库市场报告

Mammalian Cell Banking Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，哺乳动物细胞库市场发展迅速，预计从2024年的28.2亿美元成长到2025年的31.4亿美元，复合年增长率达11.5%。这一增长与单株抗体需求增加、生物製药研发投资增加、GMP合规监管要求提高、哺乳动物表现系统应用日益广泛以及生物製药核准增加等因素相关。

预计未来几年哺乳动物细胞库市场规模将快速成长，到2029年将达到47.9亿美元，复合年增长率（CAGR）为11.1%。预测期内的成长主要受以下因素驱动：细胞和基因疗法需求的成长、个人化医疗的兴起、生物製造基础设施投资的增加、生物相似药和生技改良药研发的拓展，以及应对疫情和疫苗生产的加强。预测期内的关键趋势包括：自动化和数位化追踪技术的整合、细胞培养技术的进步、再生医学的进展、无血清和无蛋白培养基的开发，以及冷冻保存和分析技术的改进。

对细胞疗法日益增长的需求预计将显着推动哺乳动物细胞库市场的扩张。细胞疗法是指利用活细胞（通常经过改造或基因工程处理）修復、替换或再生受损组织和器官的先进治疗方法，为多种疾病提供标靶解决方案。随着慢性病和罕见疾病的日益普遍，对更有效、更精准的治疗方法的需求也日益增长。哺乳动物细胞库在支持这些疗法方面发挥着至关重要的作用，它提供稳定、高品质的细胞来源，并确保再生疗法开发和生产的安全性、扩充性和可靠性。例如，美国基因与细胞治疗学会于2024年4月报告称，处于临床研发管线中的治疗方法数量正在增加，其中I期临床试验自2022年下半年以来增长最为强劲，达到11%。对细胞疗法需求的激增正在推动哺乳动物细胞库市场的成长。

慢性病发病率的上升正在推动哺乳动物细胞库市场的成长。慢性病是指需要持续管理而非治癒的长期疾病，其盛行率正在上升，尤其是在全球人口老化的情况下。老年人更容易患上需要持续照护的慢性病。哺乳动物细胞库透过提供稳定的高品质细胞来源，有助于开发稳定可靠的细胞治疗方法和生技药品，从而辅助治疗这些疾病。例如，国际糖尿病联盟在2025年4月报告称，2024年全球约有5.89亿20至79岁的成年人患有糖尿病，预计到2050年这一数字将增至8.53亿。随着慢性病盛行率的持续上升，哺乳动物细胞库服务的需求也随之成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球哺乳动物细胞库：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球哺乳动物细胞库市场：成长率分析
  • 全球哺乳动物细胞库市场表现：规模与成长，2019-2024年
  • 全球哺乳动物细胞库市场预测：规模与成长，2024-2029年，2034年
  • 全球哺乳动物细胞库：潜在市场规模 (TAM)

第六章 市场细分

  • 全球哺乳动物细胞库市场依产品类型、表现及预测划分，2019-2024年、2024-2029年、2034年
  • 主细胞库
  • 工作细胞库
  • 全球哺乳动物细胞库市场（依细胞类型划分）：表现及预测，2019-2024年、2024-2029年、2034年
  • 中国仓鼠卵巢哺乳动物细胞库（CHO）
  • 仓鼠肾臟（BHK）
  • 非秘书（NS0）
  • YB2/0 和 P2/0
  • 人类胚胎肾细胞293（HEK293）及其衍生物
  • 亨丽埃塔·拉克斯（HELA）
  • 全球哺乳动物细胞库市场依储存类型、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 液态氮
  • 控速冷冻机
  • 快速冷冻
  • 全球哺乳动物细胞库市场：依应用、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 药物研发
  • 疫苗生产
  • 基因治疗
  • 单株抗体生产
  • 全球哺乳动物细胞库市场依最终使用者、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 学术和研究机构
  • 生物製药公司
  • 受託研究机构（CRO）
  • 全球哺乳动物细胞库市场：按类型、表现和预测细分主细胞库（2019-2024年、2024-2029年、2034年）
  • 重组细胞系
  • 融合瘤细胞株
  • 原代细胞系
  • 基因工程细胞系
  • 病毒载体生产细胞株
  • 全球哺乳动物细胞库市场：依工作细胞库、类型、表现及预测细分，2019-2024年、2024-2029年、2034年
  • 符合现行良好生产规范 (cGMP) 的细胞库
  • 研究细胞库
  • 用于临床试验的细胞库
  • 商业细胞库
  • 细胞库稳定性测试

第七章 区域和国家分析

  • 全球哺乳动物细胞库市场：依地区、绩效及预测划分，2019-2024年、2024-2029年、2034年
  • 全球哺乳动物细胞库市场：依国家、绩效及预测划分，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 哺乳动物细胞库市场：竞争格局
  • 哺乳动物细胞库市场：公司概况
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Catalent Inc.
  • Sartorius Stedim Biotech SA
  • Samsung Biologics Co. Ltd.
  • CMIC Holdings Co. Ltd.
  • WuXi Biologics Inc.
  • Fujifilm Diosynth Biotechnologies Inc.
  • Evotec SE
  • AGC Biologics Inc.
  • CordenPharma International GmbH
  • GenScript ProBio Co. Ltd.
  • Syngene International Limited
  • KBI Biopharma Inc.
  • Rentschler Biopharma SE
  • BioVectra Inc.
  • Polpharma Biologics SA

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年哺乳动物细胞库市场：提供新机会的国家
  • 2029年哺乳动物细胞库市场：新兴细分市场机会
  • 2029年哺乳动物细胞库市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38568

Mammalian cell banking is the organized procedure of producing, preserving, and storing well-characterized mammalian cell stocks under strict conditions, typically at very low temperatures, to ensure their long-term survival, genetic consistency, and functional performance. This method maintains the cells' uniformity, prevents contamination, and preserves their original traits over time, providing a reliable and standardized resource for future use.

The primary types of products in mammalian cell banking are master cell bank and working cell bank. A master cell bank (MCB) is a carefully prepared and extensively characterized collection of cells stored in multiple vials under controlled cryogenic conditions. It includes various cell types such as Chinese hamster ovary (CHO), baby hamster kidney (BHK), non-secreting 0 (NS0), YB2/0 and P2/0, human embryonic kidney 293 (HEK293) and derivatives, and HeLa cells. Storage methods include liquid nitrogen, controlled-rate freezing, and flash freezing. Master cell banks are used in drug development, vaccine production, gene therapy, and monoclonal antibody production, serving end users such as academic and research laboratories, biopharmaceutical companies, and contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The mammalian cell banking market research report is one of a series of new reports from The Business Research Company that provides mammalian cell banking market statistics, including mammalian cell banking industry global market size, regional shares, competitors with a mammalian cell banking market share, detailed mammalian cell banking market segments, market trends and opportunities, and any further data you may need to thrive in the mammalian cell banking industry. This mammalian cell banking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mammalian cell banking market size has grown rapidly in recent years. It will grow from $2.82 billion in 2024 to $3.14 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth observed during the historic period can be linked to increasing demand for monoclonal antibodies, higher investment in biopharmaceutical research and development, expansion of regulatory requirements for GMP compliance, greater use of mammalian expression systems, and a rise in approvals of biologic drugs.

The mammalian cell banking market size is expected to see rapid growth in the next few years. It will grow to $4.79 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth projected for the forecast period can be attributed to increasing demand for cell and gene therapies, wider adoption of personalized medicine, rising investment in biomanufacturing infrastructure, expansion of biosimilar and biobetter development, and strengthened pandemic preparedness and vaccine production. Key trends during the forecast period include the integration of automation and digital tracking, advancements in cell culture technologies, progress in regenerative medicine, development of serum-free and protein-free media, and improvements in cryopreservation and analytical techniques.

The growing demand for cell-based therapies is expected to significantly drive the expansion of the mammalian cell banking market. Cell-based therapies involve advanced treatments using living, often modified or engineered, cells to repair, replace, or regenerate damaged tissues and organs, offering targeted solutions for various diseases. As chronic and rare diseases become more prevalent, there is an increasing need for more effective and precise treatments. Mammalian cell banking plays a key role in supporting these therapies by providing a consistent, high-quality cell source, ensuring safety, scalability, and reliability in the development and production of regenerative treatments. For example, the American Society of Gene and Cell Therapy reported in April 2024 that the number of therapies in clinical pipelines has grown, with Phase I trials showing the strongest growth of 11% since late 2022. This surge in demand for cell-based therapies is therefore fueling the growth of the mammalian cell banking market.

The rise in chronic diseases is driving the growth of the mammalian cell banking market. Chronic diseases are long-term conditions that require ongoing management instead of a cure, and their prevalence is increasing, particularly as the global population ages. Older individuals are more prone to developing chronic conditions that demand continuous care. Mammalian cell banking aids in treating these conditions by supplying high-quality, stable cells for the creation of consistent, reliable cell-based therapies and biologics. For instance, the International Diabetes Federation reported in April 2025 that around 589 million adults aged 20 to 79 were living with diabetes in 2024, and this figure is projected to rise to 853 million by 2050. As the incidence of chronic diseases continues to grow, the demand for mammalian cell banking services is also increasing.

Companies in the mammalian cell banking market are advancing the field by developing innovative stable cell line systems that improve cell line productivity, ensure long-term genetic stability, and streamline biopharmaceutical manufacturing. Stable cell line systems are engineered mammalian cells that can consistently produce specific proteins or therapeutic molecules across generations with high genetic stability. For example, WuXi Biologics, a biopharmaceutical company based in China, introduced the WuXia293 Stable platform in August 2024. This HEK293-based stable cell line system is designed for the development and production of challenging biologic molecules. By using proprietary cell line development technology, the platform ensures stable expression, consistent quality, and scalable production, overcoming challenges typically seen with traditional CHO cell systems, such as low yields and compromised quality. The WuXia293 Stable platform provides higher protein yields, better human-like glycosylation, and more efficient production for clinical and commercial use.

Major players in the mammalian cell banking market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, Eurofins Scientific SE, Charles River Laboratories International Inc., Catalent Inc., Sartorius Stedim Biotech S.A., Samsung Biologics Co. Ltd., CMIC Holdings Co. Ltd., WuXi Biologics Inc., Fujifilm Diosynth Biotechnologies Inc., Evotec SE, AGC Biologics Inc., CordenPharma International GmbH, GenScript ProBio Co. Ltd., Syngene International Limited, KBI Biopharma Inc., Rentschler Biopharma SE, BioVectra Inc., Polpharma Biologics S.A., and Abzena plc.

North America was the largest region in the mammalian cell banking market in 2024. The regions covered in mammalian cell banking report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mammalian cell banking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mammalian cell banking market consists of sales of cryopreservation media, cell culture reagents, storage vials, cryogenic storage equipment, and quality control kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammalian Cell Banking Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mammalian cell banking market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mammalian cell banking ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mammalian cell banking market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Master Cell Bank; Working Cell Bank
  • 2) By Cell Type: Chinese Hamster Ovary Mammalian Cell Banking (CHO); Baby Hamster Kidney (BHK); Non-Secreting 0 (NS0); YB2/0 And P2/0; Human Embryonic Kidney 293 (HEK293) And Derivatives; Henrietta Lacks (HELA)
  • 3) By Storage Type: Liquid Nitrogen; Controlled Rate Freezer; Flash Freezing
  • 4) By Application: Drug Development; Vaccine Production; Gene Therapy; Monoclonal Antibody Production
  • 5) By End User: Academic And Research Laboratories; Biopharmaceutical Companies; Contract Research Organizations (CROs)
  • Subsegments:
  • 1) By Master Cell Bank: Recombinant Cell Lines; Hybridoma Cell Lines; Primary Cell Lines; Genetically Engineered Cell Lines; Viral Vector Producing Cell Lines
  • 2) By Working Cell Bank: Current Good Manufacturing Practice (CGMP)-Compliant Cell Banks; Research-Grade Cell Banks; Clinical Trial Cell Banks; Commercial Production Cell Banks; Stability Testing Cell Banks
  • Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; Lonza Group AG; Eurofins Scientific SE; Charles River Laboratories International Inc.; Catalent Inc.; Sartorius Stedim Biotech S.A.; Samsung Biologics Co. Ltd.; CMIC Holdings Co. Ltd.; WuXi Biologics Inc.; Fujifilm Diosynth Biotechnologies Inc.; Evotec SE; AGC Biologics Inc.; CordenPharma International GmbH; GenScript ProBio Co. Ltd.; Syngene International Limited; KBI Biopharma Inc.; Rentschler Biopharma SE; BioVectra Inc.; Polpharma Biologics S.A.; Abzena plc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mammalian Cell Banking Market Characteristics

3. Mammalian Cell Banking Market Trends And Strategies

4. Mammalian Cell Banking Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Mammalian Cell Banking Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Mammalian Cell Banking PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Mammalian Cell Banking Market Growth Rate Analysis
  • 5.4. Global Mammalian Cell Banking Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Mammalian Cell Banking Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Mammalian Cell Banking Total Addressable Market (TAM)

6. Mammalian Cell Banking Market Segmentation

  • 6.1. Global Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Master Cell Bank
  • Working Cell Bank
  • 6.2. Global Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chinese Hamster Ovary Mammalian Cell Banking (CHO)
  • Baby Hamster Kidney (BHK)
  • Non-Secreting (NS0)
  • YB2/0 And P2/0
  • Human Embryonic Kidney 293 (HEK293) And Derivatives
  • Henrietta Lacks (HELA)
  • 6.3. Global Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Nitrogen
  • Controlled Rate Freezer
  • Flash Freezing
  • 6.4. Global Mammalian Cell Banking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Development
  • Vaccine Production
  • Gene Therapy
  • Monoclonal Antibody Production
  • 6.5. Global Mammalian Cell Banking Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Laboratories
  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • 6.6. Global Mammalian Cell Banking Market, Sub-Segmentation Of Master Cell Bank, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Recombinant Cell Lines
  • Hybridoma Cell Lines
  • Primary Cell Lines
  • Genetically Engineered Cell Lines
  • Viral Vector Producing Cell Lines
  • 6.7. Global Mammalian Cell Banking Market, Sub-Segmentation Of Working Cell Bank, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Current Good Manufacturing Practice (cGMP)-Compliant Cell Banks
  • Research-Grade Cell Banks
  • Clinical Trial Cell Banks
  • Commercial Production Cell Banks
  • Stability Testing Cell Banks

7. Mammalian Cell Banking Market Regional And Country Analysis

  • 7.1. Global Mammalian Cell Banking Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Mammalian Cell Banking Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mammalian Cell Banking Market

  • 8.1. Asia-Pacific Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mammalian Cell Banking Market

  • 9.1. China Mammalian Cell Banking Market Overview
  • 9.2. China Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mammalian Cell Banking Market

  • 10.1. India Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mammalian Cell Banking Market

  • 11.1. Japan Mammalian Cell Banking Market Overview
  • 11.2. Japan Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mammalian Cell Banking Market

  • 12.1. Australia Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mammalian Cell Banking Market

  • 13.1. Indonesia Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mammalian Cell Banking Market

  • 14.1. South Korea Mammalian Cell Banking Market Overview
  • 14.2. South Korea Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mammalian Cell Banking Market

  • 15.1. Western Europe Mammalian Cell Banking Market Overview
  • 15.2. Western Europe Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mammalian Cell Banking Market

  • 16.1. UK Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mammalian Cell Banking Market

  • 17.1. Germany Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mammalian Cell Banking Market

  • 18.1. France Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mammalian Cell Banking Market

  • 19.1. Italy Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mammalian Cell Banking Market

  • 20.1. Spain Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mammalian Cell Banking Market

  • 21.1. Eastern Europe Mammalian Cell Banking Market Overview
  • 21.2. Eastern Europe Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mammalian Cell Banking Market

  • 22.1. Russia Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mammalian Cell Banking Market

  • 23.1. North America Mammalian Cell Banking Market Overview
  • 23.2. North America Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mammalian Cell Banking Market

  • 24.1. USA Mammalian Cell Banking Market Overview
  • 24.2. USA Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mammalian Cell Banking Market

  • 25.1. Canada Mammalian Cell Banking Market Overview
  • 25.2. Canada Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mammalian Cell Banking Market

  • 26.1. South America Mammalian Cell Banking Market Overview
  • 26.2. South America Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mammalian Cell Banking Market

  • 27.1. Brazil Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mammalian Cell Banking Market

  • 28.1. Middle East Mammalian Cell Banking Market Overview
  • 28.2. Middle East Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mammalian Cell Banking Market

  • 29.1. Africa Mammalian Cell Banking Market Overview
  • 29.2. Africa Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mammalian Cell Banking Market Competitive Landscape And Company Profiles

  • 30.1. Mammalian Cell Banking Market Competitive Landscape
  • 30.2. Mammalian Cell Banking Market Company Profiles
    • 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Mammalian Cell Banking Market Other Major And Innovative Companies

  • 31.1. Catalent Inc.
  • 31.2. Sartorius Stedim Biotech S.A.
  • 31.3. Samsung Biologics Co. Ltd.
  • 31.4. CMIC Holdings Co. Ltd.
  • 31.5. WuXi Biologics Inc.
  • 31.6. Fujifilm Diosynth Biotechnologies Inc.
  • 31.7. Evotec SE
  • 31.8. AGC Biologics Inc.
  • 31.9. CordenPharma International GmbH
  • 31.10. GenScript ProBio Co. Ltd.
  • 31.11. Syngene International Limited
  • 31.12. KBI Biopharma Inc.
  • 31.13. Rentschler Biopharma SE
  • 31.14. BioVectra Inc.
  • 31.15. Polpharma Biologics S.A.

32. Global Mammalian Cell Banking Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mammalian Cell Banking Market

34. Recent Developments In The Mammalian Cell Banking Market

35. Mammalian Cell Banking Market High Potential Countries, Segments and Strategies

  • 35.1 Mammalian Cell Banking Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Mammalian Cell Banking Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Mammalian Cell Banking Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer